Medical Properties Trust (NYSE:MPW) Downgraded to “Neutral” at BNP Paribas

Medical Properties Trust (NYSE:MPW) was downgraded by stock analysts at BNP Paribas from an “outperform” rating to a “neutral” rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. They currently have a $4.00 target price on the real estate investment trust’s stock, down from their previous target price of $6.00. BNP Paribas’ price objective would suggest a potential downside of 1.36% from the stock’s current price.

Several other equities research analysts also recently commented on MPW. Truist Financial upped their price target on shares of Medical Properties Trust from $4.50 to $5.00 and gave the company a “hold” rating in a research report on Thursday, May 30th. Colliers Securities downgraded shares of Medical Properties Trust from a “buy” rating to a “neutral” rating and cut their target price for the stock from $10.00 to $4.25 in a research report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating and increased their target price for the stock from $2.00 to $5.00 in a research report on Wednesday, April 17th. StockNews.com downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 18th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $5.00 target price on shares of Medical Properties Trust in a research report on Tuesday, May 14th. Five equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $5.61.

Medical Properties Trust Stock Up 0.6 %

Shares of NYSE:MPW opened at $4.06 on Tuesday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 3.10 and a current ratio of 3.10. The company has a market cap of $2.43 billion, a PE ratio of -1.83, a price-to-earnings-growth ratio of 0.62 and a beta of 1.27. Medical Properties Trust has a 52 week low of $2.92 and a 52 week high of $10.74. The firm has a 50 day simple moving average of $4.90 and a 200 day simple moving average of $4.36.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of MPW. Vanguard Group Inc. grew its stake in Medical Properties Trust by 8.2% in the 1st quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock valued at $437,373,000 after buying an additional 7,084,981 shares during the last quarter. Norges Bank acquired a new position in Medical Properties Trust in the 4th quarter valued at $25,655,000. Deutsche Bank AG grew its stake in Medical Properties Trust by 880.2% in the 3rd quarter. Deutsche Bank AG now owns 3,951,543 shares of the real estate investment trust’s stock valued at $21,536,000 after buying an additional 3,548,423 shares during the last quarter. Goldentree Asset Management LP acquired a new position in Medical Properties Trust in the 1st quarter valued at $15,966,000. Finally, BNP Paribas Financial Markets boosted its holdings in Medical Properties Trust by 517.0% in the 4th quarter. BNP Paribas Financial Markets now owns 2,150,378 shares of the real estate investment trust’s stock valued at $10,558,000 after purchasing an additional 1,801,858 shares during the period. 71.79% of the stock is currently owned by institutional investors and hedge funds.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.